| 2004 |
FTSJ1 was identified as a homolog of E. coli RNA methyltransferase FtsJ/RrmJ, and loss-of-function mutations (splice defect, nonsense mutation, single-nucleotide deletion) cause nonsyndromic X-linked mental retardation, with patient cell lines showing complete absence or significant reduction of FTSJ1 transcripts. |
Mutation screening, direct sequencing, expression studies (RT-PCR) in patient cell lines |
American journal of human genetics |
High |
15162322
|
| 2004 |
A splice site mutation in FTSJ1 (IVS3-2A>G) causes exon 4 skipping and introduces a premature stop codon, likely producing a severely truncated protein and linking FTSJ1 to X-linked mental retardation (MRX9 family). |
Direct sequencing, RT-PCR analysis of splice products in patient samples |
Journal of medical genetics |
High |
15342698
|
| 2008 |
A splice donor mutation in FTSJ1 intron 8 (c.571+1G>A) causes intron retention, frameshift, and premature termination; mutant mRNA is degraded by nonsense-mediated mRNA decay (NMD), as demonstrated by cycloheximide rescue restoring transcript levels. |
Sequencing, RT-PCR, quantitative RT-PCR, cycloheximide (NMD inhibitor) treatment in patient lymphoblasts |
American journal of medical genetics. Part B, Neuropsychiatric genetics |
High |
18081026
|
| 2015 |
FTSJ1 is the human ortholog of yeast Trm7 and is responsible for 2'-O-methylation at C32 (Cm32) and G34 (Gm34) in tRNAPhe anticodon loop; loss-of-function FTSJ1 patient cell lines nearly completely lack Cm32 and Gm34, and have reduced peroxywybutosine (o2yW37). A missense allele FTSJ1-p.A26P specifically abolishes Gm34 but not Cm32, implicating Gm34 as a critical modification. |
Mass spectrometry-based tRNA modification analysis of patient-derived cell lines; yeast trm7 mutant complementation; biochemical analysis of Trm734 binding |
Human mutation |
High |
26310293
|
| 2019 |
Crystal structure of yeast Trm7 (FTSJ1 ortholog)-Trm734 complex reveals Trm7 has a Rossmann-fold catalytic domain, Trm734 has three WD40 β-propeller domains forming a V-shaped cleft that docks Trm7 via its C-terminal region. The D-arm of substrate tRNA is required for methylation at position 34. A point mutation in Trm7 equivalent to an FTSJ1 NSXLID patient mutation decreases methylation activity. |
X-ray crystallography, SAXS, in vitro methylation assays with tRNA transcript variants, site-directed mutagenesis |
Nucleic acids research |
High |
31586407
|
| 2020 |
FTSJ1 interacts with WDR6 as a required partner protein; the FTSJ1-WDR6 complex reconstituted in vitro performs 2'-O-methylation at position 34 of specific tRNAs, with m1G37 as a prerequisite modification. Modifications at positions 32, 34, and 37 are interdependent and occur in a hierarchical order in vivo. Loss of FTSJ1 reduces translation efficiency of UUU (Phe) codons. |
Co-immunoprecipitation, in vitro reconstitution of methyltransferase activity, mass spectrometry of tRNA modifications, codon-specific translation assay in ftsj1 KO cells |
EMBO reports |
High |
32558197
|
| 2020 |
Drosophila TRM7 orthologs CG7009 and CG5220 (functional orthologs of yeast TRM7/human FTSJ1) methylate specific tRNA anticodon positions; CG7009 methylates the wobble position 34 in tRNAPhe, tRNATrp, and tRNALeu, while CG5220 methylates position C32 in the same tRNAs and additional tRNAs. Loss of these enzymes disrupts small RNA silencing pathways and increases sensitivity to RNA virus infection. |
Genetic knockout, MALDI-TOF mass spectrometry, RiboMethSeq, phenotypic analysis (lifespan, small RNA pathway, viral sensitivity) |
Nucleic acids research |
High |
31943105
|
| 2021 |
Mouse Ftsj1 is responsible for 2'-O-methylation of 11 species of cytosolic tRNAs at the anticodon region; Ftsj1 KO selectively reduces steady-state tRNAPhe levels in the brain, causing slow decoding at Phe codons (ribosome pausing). Ribosome profiling shows reduced translation efficiency of synaptic organization/function genes. Ftsj1 KO mice exhibit immature synaptic morphology, aberrant synaptic plasticity, anxiety-like behavior, and memory deficits. |
Ftsj1 KO mouse model, LC-MS/MS tRNA modification mapping, ribosome profiling, tRNA Northern blot, synaptic morphology imaging, behavioral assays |
Science advances |
High |
33771871
|
| 2022 |
A conserved RRSAGLP motif in the DUF2428 domain of yeast Trm732 (human homolog THADA, the partner of FTSJ1 for Nm32 methylation) is required for tRNA 2'-O-methylation activity at position 32; Trm732 variants carrying mutations in this motif lose methylation activity in both yeast and human THADA. |
Site-directed mutagenesis of Trm732/THADA, in vivo yeast complementation, tRNA modification assays |
ACS omega |
Medium |
35559166
|
| 2023 |
FTSJ1 regulates tRNA 2'-O-methylation at positions 32 and 34 of multiple tRNA species; loss of FTSJ1 in human neural progenitor cells results in long and thin spine neurites upon differentiation into neurons. The same morphological defects are observed in Drosophila FTSJ1 orthologs and are associated with long-term memory deficits. |
RiboMethSeq analysis of patient-derived blood cells, transcriptome analysis, differentiation of FTSJ1-depleted human neural progenitor cells into neurons (morphological imaging), Drosophila behavioral assays |
Life science alliance |
Medium |
36720500
|
| 2025 |
Cryo-EM structure of the human FTSJ1-THADA complex with and without tRNA substrate reveals that FTSJ1 binds THADA via its C-terminal region through an interaction mode distinct from the FTSJ1-WDR6 complex. The tRNA substrate is anchored inside THADA, and key THADA residues for tRNA recognition were identified and validated biochemically; this complex mediates Nm32 modification of tRNAs. |
Cryo-electron microscopy, biochemical validation of key residues by mutagenesis |
Communications biology |
High |
40483304
|
| 2020 |
FTSJ1 mediates 2'-O-methyladenosine (Am) modification of tRNAs; overexpression of FTSJ1 in NSCLC cells inhibits proliferation and migration and promotes apoptosis, while knockdown has the opposite effect. Mechanistically, FTSJ1 overexpression decreases DRAM1 expression, and DRAM1 silencing augments the antitumor effect of FTSJ1. |
Loss- and gain-of-function assays (cell proliferation, migration, apoptosis), HPLC/MS tRNA modification quantification, RNA-seq, rescue assays, in vivo xenograft |
Cell death & disease |
Medium |
32393790
|
| 2024 |
PM2.5 suppresses FTSJ1 expression and Am tRNA modification; silencing of FTSJ1 increases PGK1 expression and translation, enhancing glycolytic metabolism (elevated lactate, pyruvate, ECAR) in NSCLC cells. Glycolytic inhibitor 2-DG reverses this effect. |
Knockdown/overexpression of FTSJ1, HPLC-MS tRNA modification analysis, glycolysis assays (ECAR, lactate, pyruvate), RNA-seq, polysome profiling (translation), xenograft |
Cell death & disease |
Medium |
39695074
|